Clinical Trials · NCT01415960
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- GP-Pharm
- Enrollment
- 163
- Start date
- Sep 2011
- Locations
- 25 sites, United States
- Primary endpoint
- Percentage of Participants Achieving Chemical Castration (Defined as Testosterone Levels ≤ 0.5 ng/mL) at Days 28, 84, and 168.